Pain
Conditions
Brief summary
This study aims to evaluate the impact of a Transitional Pain Service (TPS) on hospital readmission rates, opioid consumption, and chronic post-surgical pain(CPSP), Despite increasing recognition of the benefits of integrated transitional pain care, there are limited prospective data evaluating its impact on 30-day readmissions, longitudinal opioid use, and CPSP. This protocol will systematically collect prospective patient data to assess these outcomes.
Detailed description
Primary Objective: To compare the 30-day hospital readmission rate in patients seen by to the Transitional Pain Service. Secondary Objectives: 1. To evaluate reduction in opioid use (MME) at 30, 60, 90, 180, and 365 days. 2. To evaluate patient reported outcomes using BPI, CAGE-AID, SOAPP-14, ESAS, PROMIS-29 at 30, 60, 90, 180, and 365 days to assess patient-reported quality of life and pain outcomes longitudinally. 3. To evaluate the incidence of CPSP 4. To assess demographic and clinical predictors of readmission and opioid reduction. 5. Compare outcomes between TPS patients who receive a brief, skills-based mini-CBT group intervention vs. TPS patients who do not receive mini-CBT, including: * Time trends across 30, 60, 90 days, and 6 and 12 months. * Opioid use (daily MME), and proportion achieving ≥30% MME reduction from baseline; * Pain intensity (NRS/10), BPI severity & interference, PROMIS-29 domains; * beyond 30-day hospital readmission rate
Interventions
BEHAVIORALTransitional Pain Service
Participants will receive a brief, skills-based mini-CBT group intervention
Sponsors
M.D. Anderson Cancer Center
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Chronic pain syndrome Patients with a h/o or current substance use Patients on a daily opioid dose (morphine equivalency) of ≥90 Consulted for transitional pain service
Exclusion criteria
Not seen by transitional pain service
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Safety and Adverse Events (AEs) | Through study completion; an average of 1 year. | Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0 |
Countries
United States
Contacts
CONTACTLakshmi Koyyalagunta, MD
PRINCIPAL_INVESTIGATORLakshmi Koyyalagunta, MD
UT MD Anderson Cancer Center
Outcome results
None listed